If anyone talks bad about the stock, it only goes up so why don't more people talk bad about it if they want it to go up. The only way it goes up is if they think you might be a short. You have to play the manipulators.
As of May 20th, 2013, the SEC's new US GAAP Financial Reporting Taxonomy applies. Hill will need to improve his bookkeeping to remain compliant. See Edgar 000000000012054032
Amyris (NASDAQ:AMRS) also announced they had contracted for Biofene Manufacture with Antibióticos, S.A. in Mar 2011 when their stock was still valued at over $30/share. It's been free falling ever since. It hit $1.57 this year and is currently back on it's downward spiral toward delistment, as is MBLX. They have only survived this long due to illegal price manipulation schemes. Metabolix tries not to say much, have you noticed?
Sentiment: Strong Sell
BG Medicine was downgraded by TheStreet from hold to sell in May. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and deteriorating net income. Since the company had no net operating cash flow for the prior period, we cannot calculate a percent change in order to compare its growth rate with that of its industry average.
They have sell shares, same as printing cash, because they have a lot of expenses. It's good for them, not good for shareholders. I hope they will turn off the printing press before the ship sinks again.
Cisco using some of its cash-hoard to make acquisitions in Cloud Computing...Smart
Vonage reports earnings on Wed, so look for smart money to re-balance. 8x8 is consistently profitable and debt free. Earnings have already been released. Business customers make up 95% and they pay more. The home market is already saturated by tv ads offering cheap bundles. 8x8 doesn't make any money from these cheapskates and doesn't have to pay for any tv marketing campaign. They are all about keeping costs low, and they're growing. Employee's like working for the company, it speaks volumes.
Sentiment: Strong Buy